ArticleInvestigative ophthalmology & visual science2025
Inhibitor of DNA-Binding 3 Is a Novel Regulator of Limbal Epithelial Cell Migration Via the EphA2/Akt Signaling Pathway.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Purpose: Upon corneal injury, early and late transit amplifying (TA) cells, the progeny of epithelial stem cells, migrate to the site of the wound, which facilitates its closure. Understanding the targetable signals that guide such cell migration is essential for the development of novel wound-healing strategies. Methods: Single-cell RNA sequencing (scRNA-seq) was conducted in wild-type cornea. To investigate the role of inhibitor of DNA binding 3 (ID3) in the limbal epithelium, bulk RNA-seq was conducted in limbal epithelial cells with ID3 knockdown. hTCEpi cells were transfected with small interfering RNAs (siRNAs) against ID3, and cell migration was assessed using scratch wound assays. Results: The scRNA-seq revealed that ID3, a transcription factor, was preferentially expressed in the stem/early TA population of limbal epithelium. Bulk RNA-seq in limbal epithelial cells with ID3 knockdown suggested a role of ID3 in cell migration. Scratch wound assays confirmed that loss of ID3 in human limbal epithelial cells markedly accelerated wound sealing, indicating an inhibitory role of ID3 in cell migration. Gene Ontology analysis of the RNA-seq data suggested that ID3 negatively regulates EphA2 (a receptor tyrosine kinase) and Akt signaling, both of which have a critical role in cell migration. Consistently, loss of ID3 induced ligand-independent activation of EphA2, as well as enhanced phosphorylation of Akt proteins. Scratch wound assays demonstrated that both ligand-independent activation of EphA2 and phosphorylation of Akt were required for enhanced cell migration in cells lacking ID3. Conclusions: Our findings indicate that ID3, EphA2, and Akt form a novel signaling axis, which plays a critical role in corneal epithelial wound healing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.